药房住院药师驱动的虚拟药物基因组学门诊:利用人群仪表盘管理工具识别可能受益于检测的退伍军人
本研究在退伍军人门诊中创建由PGY2药房住院药师主导的虚拟药物基因组学门诊,使用人群仪表盘工具识别新处方VA PGx基因检测面板药物的患者。共筛查130例,104例接受检测(同意率80%),识别247个基因变异,其中78个为可操作药物-基因变异,向处方者提出90条建议。
要点
- 人群仪表盘工具可有效识别符合PGx检测条件的退伍军人。
- 住院药师驱动的虚拟门诊实现了80%的检测同意率和多数患者的PGx干预。
- 可操作变异主要涉及氯吡格雷、他汀类、舍曲林和质子泵抑制剂。
核心结论
- 新型人群仪表盘工具使用有助于识别符合PGx检测条件的患者。
- 住院药师驱动的虚拟门诊使大多数接受检测的患者获得了PGx干预。
研究设计与样本
- 研究纳入2023年3月至2024年6月在Lt. Col. Luke Weathers, Jr. VA医疗中心门诊治疗的退伍军人。
- 创建虚拟PGx门诊后,使用PGx人群仪表盘工具识别新处方VA PGx基因检测面板药物的患者。
- 门诊由PGY2药房住院药师驱动,并有带教老师监督实践,联系患者获取同意并进行检测。
主要发现
- 共筛查130例患者,其中104例接受了PGx检测,对应80%的同意率。
- 共识别247个PGx基因变异,包括149个信息性变异和78个可操作药物-基因变异,18个提示遗传性疾病的变异和17个对应表型转换的变异。
- 向处方者提出了90条建议,患者平均有2.3种受PGx影响的药物处方。
- 可操作药物-基因变异中,大多数与氯吡格雷、他汀类、舍曲林和质子泵抑制剂的使用相关。
临床怎么用
- 可利用人群仪表盘工具主动识别需要PGx检测的退伍军人。
- 药房住院药师可主导虚拟PGx门诊,完成患者联系、知情同意、检测及结果解读与建议。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Expanding access to pharmacogenomics (PGx) testing to veterans has been an emphasis in the Veterans Health Administration (VHA); using population dashboard tools (PDTs) may identify additional patients who qualify for testing. Involving pharmacy residents in PGx can help prepare them for precision medicine practice and more efficiently provide PGx care to patients. METHODS: Veterans treated in the outpatient setting at the Lt. Col. Luke Weathers, Jr. Veterans Affairs (VA) Medical Center from March 2023 to June 2024 were included in this study. Upon creation of a virtual PGx clinic, a PGx PDT was used to identify patients newly prescribed medications on the VA PGx gene testing panel. The clinic was driven by a postgraduate year 2 pharmacy resident with a preceptor overseeing the practice, and patients were contacted for consent and testing. The number and type of PGx gene variants identified were assessed, with results discussed with patients and recommendations made to providers. RESULTS: A total of 130 patients were screened, of whom 104 had PGx testing, corresponding to an 80% consent rate. Overall, 247 PGx gene variants were identified, including 149 informational and 78 actionable drug-gene variants, 18 variants indicating inheritable conditions, and 17 variants corresponding to phenoconversion. A total of 90 recommendations were made to providers, and patients had an average of 2.3 PGx-impacted medications prescribed. Of the actionable drug-gene variants, the majority were related to use of clopidogrel, statins, sertraline, and proton pump inhibitors. CONCLUSION: Novel use of a PDT was helpful in identifying patients qualifying for PGx testing. Creation of the resident-driven clinic resulted in PGx interventions for the majority of patients who underwent testing.
引用
- Jackson L, Brandl E, Neu D, et al. A pharmacy resident-driven virtual pharmacogenomics clinic: Utilizing population dashboard management tools to identify veterans who may benefit from testing. Am J Health Syst Pharm. 2025. PMID: 40202453. doi:10.1093/ajhp/zxaf090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。